Interleukin-36 receptor antagonist deficiency (DITRA) with a novel IL36RN homozygous mutation c. 200G> T (P. Cys67Phe) in a young Colombian woman

AF Zea-Vera, FE Estupiñan-Lopez… - Journal of clinical …, 2019 - Springer
AF Zea-Vera, FE Estupiñan-Lopez, J Cifuentes-Burbano, MJ Vargas, A Bonelo
Journal of clinical immunology, 2019Springer
Discussion To our knowledge, this is the first case of interleukin-36 receptor antagonist
deficiency (DITRA) reported in South America. The genetic cause and the pathogenesis for
acute generalized pustular psoriasis were unknown until 2011, when Marrakchi et al.
described nine families affected by the disease with an autosomic recessive pattern and
identified mutations of interleukin-36 receptor antagonist as a gene associated with the
disease [1]. GPP develops as a primary condition or in association with preexisting …
Discussion
To our knowledge, this is the first case of interleukin-36 receptor antagonist deficiency (DITRA) reported in South America. The genetic cause and the pathogenesis for acute generalized pustular psoriasis were unknown until 2011, when Marrakchi et al. described nine families affected by the disease with an autosomic recessive pattern and identified mutations of interleukin-36 receptor antagonist as a gene associated with the disease [1]. GPP develops as a primary condition or in association with preexisting psoriasis. However, patients, who debuted with generalized pustular psoriasis the de novo, are more likely to have IL36RN mutations [2] even more when its presentation is at early ages. In our case, symptoms began
Springer